FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892852236> ?p ?o ?g. }

• W2892852236 endingPage "41" @default.
• W2892852236 startingPage "41" @default.
• W2892852236 abstract "Dementia is common in Parkinson disease, but few data exist on dementia treatment patterns or the concurrent use of acetylcholinesterase inhibitors (ACHEIs) and anticholinergic medications, a frank prescribing error.To describe dementia treatment patterns, and to determine the extent to which the concurrent use of ACHEIs and drugs with strong anticholinergic activity occurs among individuals with Parkinson disease in the United States.This cross-sectional analysis included adult Medicare beneficiaries (aged 65 years or older) with Parkinson disease diagnosis with 12 consecutive months of inpatient, outpatient, and prescription drug coverage from January 1, 2014, through December 31, 2014. Beneficiaries with other parkinsonian syndromes were excluded. Demographic, geographic, prescription claims, and other data were extracted from the 2014 Carrier, Beneficiary Summary, and Prescription Drug Event research identifiable files of the Centers for Medicare & Medicaid Services. Data analysis was conducted from August 1, 2017, to November 30, 2017.Primary outcomes were use of dementia drug, specific dementia medication, and concurrent exposure to a high-potency anticholinergic drug and an ACHEI. Descriptive analyses and multivariable logistic regression models determined the extent to which patient characteristics and comorbid conditions were associated with dementia treatment or with a high-potency anticholinergic and ACHEI never event.Of 268 407 Medicare beneficiaries with Parkinson disease (mean [SD] age, 78.9 [7.5]; 134 575 male [50.1%]), most were identified in the files as white (232 831 [86.7%]), followed by black (14 629 [5.5%]), Hispanic (7176 [2.7%]), Asian (7115 [2.7%]), and Native American (874 [0.3%]). Among these beneficiaries, 73 093 (27.2%) were given a prescription for at least 1 antidementia medication. The most commonly prescribed medication was donepezil hydrochloride (46 027 [63.0%] users), followed by memantine hydrochloride (30 578 [41.8%] users) and rivastigmine tartrate (19 278 [26.4%] users). Dementia drugs were more likely to be prescribed to black (adjusted odds ratio [AOR], 1.33; 95% CI, 1.28-1.38) and Hispanic (AOR, 1.28; 95% CI, 1.22-1.35) beneficiaries and less likely for Native American beneficiaries (AOR, 0.62; 95% CI, 0.51-0.74). Women were less likely than men to be given a prescription for dementia medication (AOR, 0.85; 95% CI, 0.84-0.87). Of the 64 017 beneficiaries receiving an ACHEI, 28 495 (44.5%) experienced at least 1 high-potency anticholinergic-ACHEI event. Hispanic (AOR, 1.11; 95% CI, 1.00-1.23) and women (AOR, 1.30; 95% CI, 1.25-1.35) beneficiaries had greater odds of experiencing this never event. Statistically significant clusters of the prevalence of this prescribing error were observed across the United States (Moran I = 0.24; P < .001), with clusters of high prevalence in the southern and midwestern states.Dementia medication use by persons with Parkinson disease varies by race/ethnicity and sex; potentially inappropriate prescribing is common among those being treated for cognitive impairment and varies by race/ethnicity, sex, and geography. These findings may serve as national and local targets for improving care quality and outcomes for persons with Parkinson disease." @default.
• W2892852236 created "2018-10-05" @default.
• W2892852236 creator A5008134033 @default.
• W2892852236 creator A5012370449 @default.
• W2892852236 creator A5037362183 @default.
• W2892852236 creator A5052394038 @default.
• W2892852236 creator A5059156204 @default.
• W2892852236 creator A5073761403 @default.
• W2892852236 creator A5085017781 @default.
• W2892852236 date "2019-01-01" @default.
• W2892852236 modified "2023-10-10" @default.
• W2892852236 title "Patterns of Dementia Treatment and Frank Prescribing Errors in Older Adults With Parkinson Disease" @default.
• W2892852236 cites W1103435653 @default.
• W2892852236 cites W1594685544 @default.
• W2892852236 cites W1717096433 @default.
• W2892852236 cites W1885676552 @default.
• W2892852236 cites W1931878258 @default.
• W2892852236 cites W1990263121 @default.
• W2892852236 cites W2038136355 @default.
• W2892852236 cites W2046690778 @default.
• W2892852236 cites W2059797715 @default.
• W2892852236 cites W2061023290 @default.
• W2892852236 cites W2068289517 @default.
• W2892852236 cites W2087598124 @default.
• W2892852236 cites W2095755860 @default.
• W2892852236 cites W2096682568 @default.
• W2892852236 cites W2115175524 @default.
• W2892852236 cites W2115455636 @default.
• W2892852236 cites W2120387391 @default.
• W2892852236 cites W2122170860 @default.
• W2892852236 cites W2123886317 @default.
• W2892852236 cites W2133488570 @default.
• W2892852236 cites W2138737680 @default.
• W2892852236 cites W2139337687 @default.
• W2892852236 cites W2140038023 @default.
• W2892852236 cites W2141042831 @default.
• W2892852236 cites W2143471745 @default.
• W2892852236 cites W2168499550 @default.
• W2892852236 cites W2232968682 @default.
• W2892852236 cites W2236077674 @default.
• W2892852236 cites W2300412211 @default.
• W2892852236 cites W2312469094 @default.
• W2892852236 cites W2324471062 @default.
• W2892852236 cites W2408444336 @default.
• W2892852236 cites W2529284522 @default.
• W2892852236 cites W2594519269 @default.
• W2892852236 cites W2595723182 @default.
• W2892852236 cites W2616393094 @default.
• W2892852236 cites W2753252511 @default.
• W2892852236 cites W2755651073 @default.
• W2892852236 cites W2756040809 @default.
• W2892852236 cites W2761280376 @default.
• W2892852236 cites W2766213311 @default.
• W2892852236 cites W2767763205 @default.
• W2892852236 cites W2769864249 @default.
• W2892852236 cites W2895343773 @default.
• W2892852236 cites W4233731652 @default.
• W2892852236 cites W4245060729 @default.
• W2892852236 cites W4253636263 @default.
• W2892852236 doi "https://doi.org/10.1001/jamaneurol.2018.2820" @default.
• W2892852236 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6382612" @default.
• W2892852236 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30285047" @default.
• W2892852236 hasPublicationYear "2019" @default.
• W2892852236 type Work @default.
• W2892852236 sameAs 2892852236 @default.
• W2892852236 citedByCount "38" @default.
• W2892852236 countsByYear W28928522362019 @default.
• W2892852236 countsByYear W28928522362020 @default.
• W2892852236 countsByYear W28928522362021 @default.
• W2892852236 countsByYear W28928522362022 @default.
• W2892852236 countsByYear W28928522362023 @default.
• W2892852236 crossrefType "journal-article" @default.
• W2892852236 hasAuthorship W2892852236A5008134033 @default.
• W2892852236 hasAuthorship W2892852236A5012370449 @default.
• W2892852236 hasAuthorship W2892852236A5037362183 @default.
• W2892852236 hasAuthorship W2892852236A5052394038 @default.
• W2892852236 hasAuthorship W2892852236A5059156204 @default.
• W2892852236 hasAuthorship W2892852236A5073761403 @default.
• W2892852236 hasAuthorship W2892852236A5085017781 @default.
• W2892852236 hasBestOaLocation W28928522361 @default.
• W2892852236 hasConcept C118552586 @default.
• W2892852236 hasConcept C126322002 @default.
• W2892852236 hasConcept C151956035 @default.
• W2892852236 hasConcept C2426938 @default.
• W2892852236 hasConcept C2776291444 @default.
• W2892852236 hasConcept C2778689640 @default.
• W2892852236 hasConcept C2778858636 @default.
• W2892852236 hasConcept C2779056891 @default.
• W2892852236 hasConcept C2779134260 @default.
• W2892852236 hasConcept C2779483572 @default.
• W2892852236 hasConcept C2780904820 @default.
• W2892852236 hasConcept C71924100 @default.
• W2892852236 hasConcept C74909509 @default.
• W2892852236 hasConcept C98274493 @default.
• W2892852236 hasConceptScore W2892852236C118552586 @default.
• W2892852236 hasConceptScore W2892852236C126322002 @default.
• W2892852236 hasConceptScore W2892852236C151956035 @default.
• W2892852236 hasConceptScore W2892852236C2426938 @default.

• next